SUVRETTA CAPITAL MANAGEMENT, LLC

Position in ABT — Abbott Laboratories

CIK 1569064 New York, NY

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,072,320

-$798,356 QoQ

Shares Held

66,920

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#631

of 2,959 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC holds $23,058,804 across 7 Medical Devices names. ABT ranks #2 (26.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DXCM	Dexcom Inc	101,980	$6,868,353
2	ABT	Abbott Laboratories This page	66,920	$6,072,320
3	BSX	Boston Scientific Corp	140,083	$5,978,742
4	SYK	Stryker Corp	5,860	$1,844,962
5	EW	Edwards Lifesciences Corp	18,700	$1,691,602
6	STE	STERIS plc	1,530	$322,172
7	ZBH	Zimmer Biomet Holdings, Inc.	3,260	$280,653

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,072,320	66,920	0.0%	Shares	Sole	2026-08-14
2026-03-31	$6,870,676	66,920	+31.2%	Shares	Sole	2026-05-15
2025-12-31	$6,392,295	51,020	0.0%	Shares	Sole	2026-02-17
2025-09-30	$6,833,618	51,020	+25.9%	Shares	Sole	2025-11-14
2025-06-30	$5,511,125	40,520	-31.1%	Shares	Sole	2025-08-14
2025-03-31	$7,802,473	58,820	+75.5%	Shares	Sole	2025-05-15
2024-12-31	$3,791,447	33,520	0.0%	Shares	Sole	2025-02-14
2024-09-30	$3,821,615	33,520	0.0%	Shares	Sole	2024-11-14
2024-06-30	$3,483,063	33,520	0.0%	Shares	Sole	2024-08-14
2024-03-31	$3,809,883	33,520	0.0%	Shares	Sole	2024-05-15
2023-12-31	$3,689,546	33,520	+62.6%	Shares	Sole	2024-02-14
2023-09-30	$1,997,047	20,620	0.0%	Shares	Sole	2023-11-14
2023-06-30	$2,247,992	20,620	0.0%	Shares	Sole	2023-08-14
2023-03-31	$2,087,981	20,620	+100.0%	Shares	Sole	2023-05-15
2022-12-31	$1,131,934	10,310	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.